Search

Your search keyword '"Spurr, Liam"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Spurr, Liam" Remove constraint Author: "Spurr, Liam"
233 results on '"Spurr, Liam"'

Search Results

3. Emergency Department Preparedness to Care for Sexual Assault Survivors: A Nationwide Study

6. Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC

7. Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade

9. Clinicogenomic characterization of inflammatory breast cancer

12. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

13. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer

16. Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer.

17. PATH-12. CONTEMPORARY MOLECULAR LANDSCAPE, SURVIVAL, AND PROGNOSTIC FACTORS IN OVER 4,000 GLIOMAS

19. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer

20. Mechanisms and therapeutic implications of hypermutation in gliomas

22. Molecular Landscape and Contemporary Prognostic Signatures of Gliomas

23. Data from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

24. Supplementary Figures Legends from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

25. Supplementary Tables from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

26. Figure S6 from Discovery and Features of an Alkylating Signature in Colorectal Cancer

27. Data from Discovery and Features of an Alkylating Signature in Colorectal Cancer

28. Data from FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

29. Supplementary Data from Discovery and Features of an Alkylating Signature in Colorectal Cancer

30. Supplementary Data from FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

31. Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

32. Supplementary Data from Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer

33. Supplementary Data from Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

34. Supplementary Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

35. Supplementary Figures from Genomic Characterization of de novo Metastatic Breast Cancer

36. Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma

37. STK11Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer

40. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

41. Chromosomal instability mediates immune exclusion and response to cytotoxic chemotherapy in colorectal liver metastases

42. Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q

43. Abstract NG01: Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in cancers harboring loss of chromosome 18q or 16q

45. Discovery and Features of an Alkylating Signature in Colorectal Cancer

48. FGFR2Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

49. Genomic Characterization of de novo Metastatic Breast Cancer

50. Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

Catalog

Books, media, physical & digital resources